Fig. 3From: NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumorsDiffuse immunoreactivity of NKX2.2 compared to patchy immunoreactivity of CDX-2 in representative pancreatic well-differentiated neuroendocrine tumors. a H&E staining. b NKX2.2. c CDX-2. Original magnification, 400×Back to article page